David O'Malley, MD | Authors

David O’Malley, MD, Discusses Findings From the OReO Trial in Ovarian Cancer at 2021 ESMO

September 23, 2021

CancerNetwork® sat down with David O’Malley, MD, at the 2021 European Society for Medical Oncology to talk about the OReO trial and how these findings impact what’s already known about PARP inhibitors for the treatment of ovarian cancer.